Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Comparing the Efficacy and Safety of Tafasitamab Plus Lenalidomide in Addition to R-CHOP Versus R-CHOP in Previously Untreate
Sponsored by MorphoSys AG (Germany)
$650.5K Funding
1 People
External
Related Topics
cancer treatment,
clinical trial,
immunotherapy,
combination therapy,
lymphoma
People
Lora Inclan
(CD)
Cancer Center Division
﹒Clinical Research Coordinator III
